WallStSmart

Spectral AI Inc. (MDAI)vsStryker Corporation (SYK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stryker Corporation generates 149126% more annual revenue ($25.27B vs $16.93M). SYK leads profitability with a 13.2% profit margin vs -82.0%. SYK earns a higher WallStSmart Score of 59/100 (C).

MDAI

Avoid

17

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 4.7Quality: 5.0
Piotroski: 4/9Altman Z: -4.12

SYK

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 6.5Value: 4.0Quality: 6.5
Piotroski: 3/9Altman Z: 2.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDAIFair Value (-2.7%)

Margin of Safety

-2.7%

Fair Value

$1.50

Current Price

$1.89

$0.39 premium

UndervaluedFair: $1.50Overvalued
SYKSignificantly Overvalued (-35.2%)

Margin of Safety

-35.2%

Fair Value

$223.02

Current Price

$305.66

$82.64 premium

UndervaluedFair: $223.02Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDAI1 strengths · Avg: 10.0/10
Debt/EquityHealth
-1.1310/10

Conservative balance sheet, low leverage

SYK1 strengths · Avg: 9.0/10
Market CapQuality
$112.44B9/10

Large-cap with strong market position

Areas to Watch

MDAI4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$64.60M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-2308.0%2/10

ROE of -2308.0% — below average capital efficiency

Revenue GrowthGrowth
-40.5%2/10

Revenue declined 40.5%

SYK3 concerns · Avg: 3.7/10
P/E RatioValuation
33.9x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : MDAI

The strongest argument for MDAI centers on Debt/Equity.

Bull Case : SYK

The strongest argument for SYK centers on Market Cap. PEG of 1.43 suggests the stock is reasonably priced for its growth.

Bear Case : MDAI

The primary concerns for MDAI are EPS Growth, Market Cap, Return on Equity.

Bear Case : SYK

The primary concerns for SYK are P/E Ratio, Revenue Growth, Piotroski F-Score.

Key Dynamics to Monitor

MDAI profiles as a turnaround stock while SYK is a value play — different risk/reward profiles.

MDAI carries more volatility with a beta of 1.16 — expect wider price swings.

SYK is growing revenue faster at 2.6% — sustainability is the question.

SYK generates stronger free cash flow (415M), providing more financial flexibility.

Bottom Line

SYK scores higher overall (59/100 vs 17/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Spectral AI Inc.

HEALTHCARE · MEDICAL DEVICES · USA

Spectral MD Holdings, Ltd., a predictive analytics company, develops AI algorithms and optical technology in wound care treatment. The company is headquartered in Dallas, Texas.

Stryker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Visit Website →

Want to dig deeper into these stocks?